| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/03/2014 | US20140186368 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 07/03/2014 | US20140186365 Antibodies that specifically bind to serum albumin without interfering with albumin's capability to interact with the fcrn |
| 07/03/2014 | US20140186364 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 07/03/2014 | US20140186363 Magea3 binding antibodies |
| 07/03/2014 | US20140186362 Anti-Interferon Gamma Antibodies And Methods Of Use Thereof |
| 07/03/2014 | US20140186361 Stable Aqueous Formulations of Adalimumab |
| 07/03/2014 | US20140186360 Phosphorylcholine conjugates and corresponding antibodies |
| 07/03/2014 | US20140186359 Pharmaceutical composition for treatment and/or prophylaxis of cancer |
| 07/03/2014 | US20140186358 Her3 antibodies binding to the beta-hairpin of her3 |
| 07/03/2014 | US20140186355 Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F |
| 07/03/2014 | US20140186354 Anti-her3/her4 antibodies binding to the beta-hairpin of her3 and the beta-hairpin of her4 |
| 07/03/2014 | US20140186353 Treatment Of Inflammatory Diseases By Inhibiting Cold-Inducible RNA-Binding Protein (CIRP) |
| 07/03/2014 | US20140186352 Anti-granulysin antibodies and methods of use thereof |
| 07/03/2014 | US20140186349 Human cdr-grafted antibody and antibody fragment thereof |
| 07/03/2014 | US20140186348 Humanized and chimeric anti-properdin antibodies |
| 07/03/2014 | US20140186347 Extending time to disease progression or survival in cancer patients |
| 07/03/2014 | US20140186346 Methods of treating pain using an il-31ra or osmr-b antagonist |
| 07/03/2014 | US20140186345 Method of administering an antibody |
| 07/03/2014 | US20140186344 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 07/03/2014 | US20140186343 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof |
| 07/03/2014 | US20140186342 Compositions and Methods for Diagnosing and Treating Cancer |
| 07/03/2014 | US20140186341 Methods for improving drug efficacy |
| 07/03/2014 | US20140186340 Methods and Compositions for Normalization of Tumor Vasculature by Inhibition of LOXL2 |
| 07/03/2014 | US20140186339 Compositions and methods for treating ocular diseases and conditions |
| 07/03/2014 | US20140186338 Genetic Products Differentially Expressed In Tumors And The Use Thereof |
| 07/03/2014 | US20140186334 Surface, anchored fc-bait antibody display system |
| 07/03/2014 | US20140186311 Transient immortalization |
| 07/03/2014 | US20140186296 Methods for Treatment of HIV and Other Infections Using a T-Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 07/03/2014 | CA2862067A1 Pharmaceutical composition of recombinant polyclonal immunoglobulins |
| 07/02/2014 | EP2749641A1 Cancer stem cell isolation |
| 07/02/2014 | EP2749573A1 Agr2 blocking antibody and use thereof |
| 07/02/2014 | EP2749572A1 Novel anti-ddr1 antibody having anti-tumor activity |
| 07/02/2014 | EP2749571A2 Methods of treating pain and inflammation in neuronal tissue using IL-31RA and OSMRb antagonists |
| 07/02/2014 | EP2749570A2 Staphylococcus aureus specific human recombinant polyclonal antibodies and uses thereof |
| 07/02/2014 | EP2748334A1 A protein involved in detection of cancer metastasis and a treatment thereof |
| 07/02/2014 | EP2748203A1 Fn14 binding proteins and uses thereof |
| 07/02/2014 | EP2748202A1 Bispecific antigen binding molecules |
| 07/02/2014 | EP2748201A1 Bispecific t cell activating antigen binding molecules |
| 07/02/2014 | EP2748200A1 Fc-free antibodies comprising two fab fragments and methods of use |
| 07/02/2014 | EP2748199A1 Anti-ox40 antibodies and methods of using the same |
| 07/02/2014 | EP2748198A2 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 07/02/2014 | EP2748197A2 Tandem fc bispecific antibodies |
| 07/02/2014 | EP2748196A1 Anti-vcam-1 nanobodies |
| 07/02/2014 | EP2748195A1 Anti-mcsp antibodies |
| 07/02/2014 | EP2748194A1 Clostridium difficile antibodies |
| 07/02/2014 | EP2748193A1 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| 07/02/2014 | EP2748186A1 Method for removing immunosuppresive properties of hiv envelope glycoproteins |
| 07/02/2014 | EP2748184A1 Multi-strain-reactive antibodies for therapy and diagnosis of influenza |
| 07/02/2014 | EP2747783A2 Biological materials related to c-met |
| 07/02/2014 | EP2747782A1 Prolonged inhibition of interleukin-6 mediated signaling |
| 07/02/2014 | EP2747781A1 Bispecific antibodies specific for t-cell activating antigens and a tumor antigen and methods of use |
| 07/02/2014 | EP2747776A2 Compounds for use in boosting coagulation |
| 07/02/2014 | CN103907026A 标定试剂和方法 Calibration reagents and methods |
| 07/02/2014 | CN103906842A 体内adcc模型 Adcc in vivo model |
| 07/02/2014 | CN103906767A 对类风湿关节炎的治疗 The treatment of rheumatoid arthritis |
| 07/02/2014 | CN103906766A 抗cd83激动剂抗体用于治疗自身免疫疾病的用途 Anti-cd83 agonist antibody for the treatment of autoimmune diseases uses |
| 07/02/2014 | CN103906765A 抗肿瘤坏死因子-α试剂及其用途 Anti-tumor necrosis factor -α agents and their use |
| 07/02/2014 | CN103906764A 犬源化抗体及其制备方法 Dog humanized antibodies and methods |
| 07/02/2014 | CN103906763A 能够中和系统发育群1和系统发育群2的a型流感病毒以及b型流感病毒的人结合分子 Capable of and phylogenetic groups 1 and a type A influenza virus and human influenza virus type b phylogenetic group 2 binding molecules |
| 07/02/2014 | CN103906762A 在混合式层析中去除杀病毒剂 In the hybrid chromatography removed virucide |
| 07/02/2014 | CN103898615A 一种黄曲霉毒素纳米抗体基因库、构建方法、用途及黄曲霉毒素m1纳米抗体2014afm-g2 One kind of aflatoxin Nanobody gene library construction method, use and aflatoxin m1 Nanobody 2014afm-g2 |
| 07/02/2014 | CN103898205A 半胱氨酸蛋白酶抑制剂sn的应用 Application of cystatin sn |
| 07/02/2014 | CN103898139A 一种新型基因重组纯蛋白抗原的制备工艺 A new preparation of pure recombinant protein antigens |
| 07/02/2014 | CN103898065A 抗大肠杆菌o157:h7单克隆抗体及应用 Anti-coli o157: h7 and application of monoclonal antibodies |
| 07/02/2014 | CN103898064A 一种抗泡球蚴囊壁组织(生发层、角皮层)单克隆抗体的制备和应用 Preparation and application of an anti-alveolar hydatid cyst tissue (germinal layers, angular cortex) monoclonal antibody |
| 07/02/2014 | CN103898045A 定形内胚层 Endoderm |
| 07/02/2014 | CN103897063A 免疫球蛋白恒定区Fc受体结合剂 Immunoglobulin constant region Fc receptor binding agent |
| 07/02/2014 | CN103897062A 一种抗甲基苯丙胺的卵黄抗体的制备方法 Preparation of an anti-methamphetamine yolk antibodies |
| 07/02/2014 | CN103897061A 阻断西妥昔单抗和egfr结合的抗体、其试剂盒及杂交瘤细胞 Blocking cetuximab and egfr binding antibody kit and hybridoma |
| 07/02/2014 | CN103897060A 一种烟曲霉蛋白单克隆抗体及其制备方法和用途 One kind of Aspergillus fumigatus protein monoclonal antibody and its preparation method and use |
| 07/02/2014 | CN103897059A 抗cd20抗原的抗体l5h7及其应用 Anti-cd20 antigen antibody l5h7 its application |
| 07/02/2014 | CN103897058A 结合cxcr4的人类抗体及其用途 Binding cxcr4 human antibody and uses thereof |
| 07/02/2014 | CN103897057A 多价抗体片段与其三聚复合物 The multivalent antibody fragment with its trimeric complex |
| 07/02/2014 | CN103897056A 可辨认感染性普立昂蛋白质的单株抗体及其用途 PolyOne Aung identifiable infectious protein monoclonal antibodies and their use |
| 07/02/2014 | CN103897055A 提高腹水型单抗产量的方法 Improve ascites monoclonal antibody production methods |
| 07/02/2014 | CN103897051A 一种华支睾吸虫特异性ppmp型抗原 One kind clonorchiasis ppmp specific antigen |
| 07/02/2014 | CN103897045A 抗革兰氏阳性细菌疫苗中的Cna_B结构域 Against Gram-positive bacteria vaccine Cna_B domain |
| 07/02/2014 | CN103896789A 秋水仙碱半抗原、抗原及其多克隆抗体的制备方法和应用 Colchicine hapten, antigen and polyclonal antibody preparation and application |
| 07/02/2014 | CN103893759A 抗vegf抗体 Anti-vegf antibody |
| 07/02/2014 | CN103160471B 赭曲霉毒素a杂交瘤细胞株和抗体与复合免疫吸附剂和免疫亲和柱与试剂盒及其应用 Ochratoxin a hybridoma cell lines and antibody and immune complex immunosorbent affinity column with the kit and its application |
| 07/02/2014 | CN103073634B 一种抗除草剂莎稗磷的特异性抗体 An anti-herbicide anilofos specific antibodies |
| 07/02/2014 | CN102778562B 证明cd44表面表达的细胞的细胞毒性介导 Mediated cytotoxicity proof cell surface expression of cd44 |
| 07/02/2014 | CN102341496B 具有抗绿脓杆菌作用的人源化PcrV抗体 Effect of human anti-Pseudomonas aeruginosa having a humanized antibody PcrV |
| 07/02/2014 | CN102190728B 一种人源化抗cd20单克隆抗体 A humanized monoclonal antibody anti-cd20 |
| 07/02/2014 | CN102066419B 人源化抗因子d抗体及其用途 The humanized anti-Factor antibodies, and uses d |
| 07/02/2014 | CN102016026B 含有来自丙型肝炎病毒的嵌合基因的核酸 Nucleic acid comprising a chimeric gene derived from the hepatitis C virus |
| 07/02/2014 | CN101802013B 人源化抗cd79b抗体和免疫偶联物及使用方法 Humanized antibodies and immunoconjugates of anti cd79b and methods of use thereof |
| 07/02/2014 | CN101370832B 结合多肽及其用途 Binding polypeptides and uses thereof |
| 07/02/2014 | CN101080419B 利用血管生成素样4蛋白的组合物和方法 The composition and method of angiopoietin-like 4 protein |
| 07/02/2014 | CN101072795B 针对流感病毒m2蛋白的人单克隆抗体 Monoclonal antibody against human influenza virus protein m2 |
| 07/01/2014 | US8766038 Methods for modifying plant morphology, biochemistry and physiology |
| 07/01/2014 | US8765920 Tyrosine bioconjugation through aqueous Ene-like reactions |
| 07/01/2014 | US8765919 TOX3 as a biomarker for breast cancer |
| 07/01/2014 | US8765918 Human antibodies that bind human interleukin-12 |
| 07/01/2014 | US8765916 ERG monoclonal antibodies |
| 07/01/2014 | US8765685 Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP) |
| 07/01/2014 | US8765665 Albumin-free factor VIII formulations |
| 07/01/2014 | US8765662 NOGO receptor binding protein |
| 07/01/2014 | US8765413 Cell cultivation process |
| 07/01/2014 | US8765389 Genetic products which are differentially expressed in tumors and use thereof |